Skip to content
Homepage
Author:
Levicept
Posted Date:
July 7, 2026
Levicept Appoints Darlene Deptula-Hicks as CFO
Levicept
July 7, 2026
Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026
Levicept
June 3, 2026
Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
Levicept
April 24, 2026
Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis
Levicept
March 30, 2026
Levicept Announces the Appointment of James Sandy as Chief Development Officer
Levicept
February 4, 2026
